Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GK.2.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GK.2.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GK.2.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.2.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.2.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GK.2.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GK.2.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GK.2.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FW.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FW.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FW.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FW.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FW.1.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FW.1.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FW.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FW.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HN.3.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HN.3.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HN.3.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HN.3.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HN.3.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
HN.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
HN.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HN.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.1.1.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.1.1.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.1.1.17ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.1.1.17ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.1.1.17EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.1.1.17EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.1.1.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.1.1.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.174EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.174EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.174ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.174ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.174EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.174EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.174ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.174ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.88 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.88 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.88 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.88 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.88 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.88 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.88 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.88 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.106 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.106 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used